Insulin-like growth factor-I receptor signal transduction: At the interface between physiology and cell biology

Comparative Biochemistry and Physiology - B Biochemistry and Molecular Biology

Volumn 121, Issue 1, 1998, Pages 19-26

  Butler, Andrew A ^a,b   Yakar, Shoshana ^a   Gewolb, Ira H ^a   Karas, Michael ^a   Okubo, Yumiko ^a   LeRoith, Derek ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cell biology; Insulin like growth factor I receptor; Physiology; Signal transduction

Indexed keywords

INSULIN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

AUTOPHOSPHORYLATION; CELL ACTIVATION; CONFERENCE PAPER; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0031743951     PISSN: 03050491     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-0491(98)10106-2     Document Type: Conference Paper

References (59)

1. 2+-ATPases in muscle and heart. J Biol Chem 1997;272(38):23696-702.
2. Araki E, Lipes MA, Patti ME, et al. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 1994;372(6502):186-90.
3. Backer JM, Myers MG Jr., Shoelson SE, et al. Phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J 1992;11(9):3469-79.
4. Beitner-Johnson D, LeRoith D. Insulin-like growth factor-I stimulates tyrosine phosphorylation of endogenous c-Crk. JBC 1995;270(10):5187-90.
5. Bonfini L, Migliaccio E, Pelicci G, Lanfrancone L, Pelicci PG. Not all Shc's roads lead to Ras. Trends Biochem Sci 1996;21(7): 257-61.
6. Bruning JC, Winnay J, Cheatham B, Kahn CR. Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells. Mol Cell Biol 1997;17(3):1513-21.
7. Butler AA, Blakesley VA, Koval A, DeJong R, Groffen J, LeRoith D. In vivo regulation of CrkII and CrkL proto-oncogenes in the uterus by insulin-like growth factor-I. Differential effects on tyrosine phosphorylation and association with paxillin. J Biol Chem 1997;272(44):27660-4.
8. Case RD, Piccione E, Wolf G, et al. SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides. J Biol Chem 1994;269(14):10467-74.
9. Chook YM, Gish GD, Kay CM, Pai EF, Pawson T. The Grb2-mSosl complex binds phosphopeptides with higher affinity than Grb2. J Biol Chem 1996;271(48):30472-8.
10. Craparo A, Freund R, Gustafson TA. 14-3-3 (epsilon) interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine-dependent manner. J Biol Chem 1997;272(17):11663-9.
11. Craparo A, O'Neill TJ, Gustafson TA. Non-SH2 domains within insulin receptor substrate-1 and SHC mediate their phosphotyrosine-dependent interaction with the NPEY motif of the insulin-like growth factor I receptor. J Biol Chem 1995;270(26): 15639-43.
12. D'Mello SR, Borodezt K, Soltoff SP. Insulin-like growth factor and potassium depolarization maintain neuronal survival by distinct pathways: possible involvement of PI 3-kinase in IGF-1 signaling. J Neurosci 1997;17(5):1548-60.
13. Datta SR, Dudek H, Tao X, et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997;91:231-41.
14. del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997;278:687-9.
15. Dey BR, Frick K, Lopaczynski W, Nissley SP, Furlanetto RW. Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, SHC, and Grb10. Mol Endocrinol 1997;10(6):631-41.
16. Dong LQ, Du H, Porter SG, et al. Cloning, chromosome localization, expression, and characterization of a src homology 2 and pleckstrin homology domain-containing insulin receptor binding protein hGrb10gamma. J Biol Chem 1997;272(46): 29104-12.
17. Dudek H, Datta SR, Franke TF, et al. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997;275(5300):661-5.
18. Feller SM, Ren R, Hanafusa H, Baltimore D. SH2 and SH3 domains as molecular adhesives: the interaction of Crk and Abl. Trends Biochem Sci 1994;19(11):453-8.
19. Frantz JD, Giorgetti-Peraldi S, Ottinger EA, Shoelson SE. Human GBR-IRbeta/GRB10. Splice variants of an insulin and growth factor receptor-binding protein with PH and SH2 domains. J Biol Chem 1997;272(5):2659-67.
20. Freestone NS, Ribaric S, Mason WT. The effect of insulin-like growth factor-1 on adult rat cardiac contractility. Mol Cell Biochem 1996;163-164:223-9.
21. Froesch ER, Hussain MA, Schmid C, Zapf J. Insulin-like growth factor I: physiology, metabolic effects and clinical uses. Diabetes Metab Rev 1996;12(3):195-215.
22. He W, Craparo A, Zhu Y, et al. Interaction of insulin receptor substrate-2 (IRS-2) with the insulin and insulin-like growth factor I receptors. Evidence for two distinct phosphotyrosine-dependent interaction domains within IRS-2. J Biol Chem 1996;27(20):11641-5.
23. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995;16(1):3-34.
24. Kaburagi Y, Satoh S, Tamemoto H, et al. Role of insulin receptor substrate-1 and pp60 in the regulation of insulin-induced glucose transport and GLUT4 translocation in primary adipocytes. J Biol Chem 1997;272(41):25839-44.
25. Kulik G, Klippel A, Weber MJ. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol Cell Biol 1997;17(3):1595-606.
26. Lavan BE, Fantin VR, Chang ET, Lane WS, Keller SR, Lienhard GE. A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells in a new member of the insulin receptor substrate family. J Biol Chem 1997;272(34):21403-7.
27. Lavan BE, Lane WS, Lienhard GE. The 60-kDa phosphoty-rosine protein in insulin-treated adipocytes in a new member of the insulin receptor substrate family. J Biol Chem 1997;272(17): 11439-43.
28. Laviola L, Giorgino F, Chow JC, et al. The adapter protein GrblO associates preferentially with the insulin receptor as compared with the IGF-I receptor in mouse fibroblasts. J Clin Invest 1997;99(5):830-7.
29. Lee CH, Li W, Nishimura R, et al. Nek associates with the SH2 domain-docking protein IRS-I in insulin-stimulated cells. Proc Natl Acad Sci USA 1993;90(24):11713-7.
30. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr. Molecular and cellular aspects of the insulin-like growth factor-I receptor. Endocr Rev 1995;16(12):143-64.
31. Lui JP, Baker J, Perkins AS, Roberts EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-1) and type 1 IGF receptor (Igflr). Cell 1993; 75(1):59-72.
32. Lui Q, Schacher D, Hurth C, Freund GG, Dantzer R, Kelley KW. Activation of phosphatidylinositol 3′-kinase by insulin-like growth factor-I rescues promyeloid cells from apoptosis and permits their differentiation into granulocytes. J Immunol 1997;159(2):829-37.
33. Louvi A, Accili D, Efstratiadis A. Growth promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev Biol 1997;189(1):33-48.
34. Marte BM, Downward J, Deprez J, et al. PKB/Akt : connecting phosphoinositide 3-kinase to cell survival and beyond. Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other kinases of the insulin signalling cascade. Trends Biochem Sci 1997;22(9):355-8.
35. Matsuda M, Tanaka S, Nagata S, Kojima A, Kurata T, Shibuya M. Two species of human Crk cDNA encode proteins with distinct biological activities. Mol Cell Biol 1992;12:3482-9.
36. Migliaccio E, Mele S, Salcini AE, et al. Opposite effects of the p52Sch, p46Sch and p66Sch splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. EMBO J 1997; 16(4):706-16.
37. Minshall C, Arkins S, Freund GG, Kelley KW. Requirements for phosphatidylinisotol 3′-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor. J Immunol 1996;156(3):939-47.
38. Minshall C, Arkins S, Straza J, et al. IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors. J Immunol 1997;159(3):1225-32.
39. Morrione A, Valentinis B, Resnicoff M, Xu S, Baserga R. The role of mGrb10alpha in insulin-like growth factor I-mediated growth. J Biol Chem 1997;272(42):26382-7.
40. Myers MG Jr., Wang LM, Sun XJ, et al. Role of IRS-1-GRB-2 complexes in insulin signalling. Mol Cell Biol 1994;14(6):3577-87.
41. O'Neill TJ, Rose DW, Pillay TS, Hotta K, Olefsky JM, Gustafson TA. Interaction of a GBR-IR splice variant (a human GRB10 homolog) with the insulin and insulin-like growth factor I receptors. Evidence for a role in mitogenic signaling. J Biol Chem 1996;271(37):22506-13.
42. Ooi J, Yajnik V, Immanuel D, et al. The cloning of Grb10 reveals a new family of SH2 domain proteins. Oncogene 1995; 10(8):1621-30.
43. Parrizas M, Saltiel AR, LeRoith D. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated kinase pathways. J Biol Chem 1997;272(1): 154-61.
44. Parrizas M, Saltiel AR, LeRoith D. Insulin-like growth factor 1 inhibition apoptosis is associated with increased expression of the Bcl-xL gene product. Endocrinology 1997;138(3):1355-8.
45. Patti ME, Sun XJ, Bruening JC, et al. 4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice. J Biol Chem 1995;270(42):24670-3.
46. Peterson JE, Jelinek T, Kaleko M, Siddle K, Weber MJ. Phosphorylation and activation of the IGF-I receptor in src-transformed cells. J Biol Chem 1994;269(44):27315-21.
47. Ponting CP, Bork P. Pleckstrin's repeat performance; a novel domain in G-protein signaling? Trends Biochem Sci 1996;21(7): 245-6.
48. Ricketts WA, Rose DW, Shoelson S, Olefsky JM. Functional roles of the She phosphotyrosine binding and Src homology 2 domains in insulin and epidermal growth factor signaling. J Biol Chem 1996;27(42):26165-9.
49. Sasaoka T, Ishiki M, Sawa T. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways. Endocrinology 1996;137(10):4427-34.
50. Sasaoka T, Rose DW, Jhun BH, Saltiel AR, Draznin B, Olefsky JM. Evidence for a functional role of She proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor. J Biol Chem 1994;269(18):13689-94.
51. Sciacchitano S, Taylor SI. Cloning, tissue expression, and chromosomal localization of the mouse IRS-3 gene. Endocrinology 1997;138(11):4931-40.
52. Seely BL, Reichart DR, Staubs PA, et al. Localization of the insulin-like growth factor I receptorbinding sites for the SH2 domain protein p85, Syp, and GTPase activating protein. J Biol Chem 1995;270(32):19151-7.
53. Sun XJ, Pons S, Asano T, Myers MG Jr., Glasheen E, White MF. The Fyn tyrosine kinase binds IRS-1 and forms a distinct signaling complex during insulin stimulation. J Biol Chem 1996;271(18):10583-7.
54. Sun XJ, Pons S, Wang LM, et al. The IRS-2 gene on murine chromosome 8 encodes a unique signaling adapter for insulin and cytokine action. Mol Endocrinol 1997;11:251-62.
55. Sun XJ, Rothenberg P, Kahn CR, et al. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 1991;352(6330):73-7.
56. Tamemoto H, Kadowaki T, Tobe K, et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 1994;372:182-6.
57. Tartare-Deckert S, Murdaca J, Sawka-Verhelle D, Holt KH, Pessin JE, Van Obberghen E. Interaction of the molecular weight 85K regulatory subunit of the phosphatidylinositol 3-kinase with the insulin receptor and the insulin-like growth factor-1 (IGF-1) receptor: comparative study using the yeast two-hybrid system. Endocrinology 1996;137(3):1019-24.
58. Tartare-Deckert S, Sawka-Verhelle D, Murdaca J, Van Obberghen E. Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with insulin-like growth factor-1 (IGF-1) receptor in the yeast two-hybrid system. J Biol Chem 1995;270(40):23456-60.
59. ten Hoeve J, Morris C, Heisterkamp H, Groffen J Grof. Isolation and chromosomal localization of CRKL, a human Crk-like gene. Oncogene 1993;8:2469-74.